https://bcibrief.com/briefing/ The developments that matter in brain-computer interfaces, with the evidence, the context and why they matter. en-GB Thu, 08 Oct 2026 12:00:00 GMT https://bcibrief.com/briefing/ https://bcibrief.com/briefing/#edition-2026-10-08 Thu, 08 Oct 2026 12:00:00 GMT Edition Speech carries this edition. One implant decoded speech and gesture together in a peer-reviewed study, and Paradromics says its first participant is choosing her own words, with no figures released yet. Around it: a $250M round for surface arrays, a company-reported decoding record, an open benchmark for decoding across subjects, and a retinal implant on the European market. In this edition: One implant, two channels of communication; Paradromics reports real-time speech from its first study participant; Neuralink says pooled participant data pushed cursor control to 11.32 bits per second; Precision Neuroscience raises $250M to take its surface array beyond thirty days; LibriBrain100 turns cross-subject speech decoding into an open competition; A retinal implant becomes the first of the new generation to reach the market. https://bcibrief.com/article/neuralink-pretraining-record/ https://bcibrief.com/article/neuralink-pretraining-record/ Thu, 01 Oct 2026 12:00:00 GMT Technology The company reports that decoders pretrained on more than 50,000 hours of neural recordings set a new internal record and cut weekly recalibration. The results are not peer reviewed. Evidence: company reported. https://bcibrief.com/article/precision-series-d/ https://bcibrief.com/article/precision-series-d/ Fri, 25 Sep 2026 12:00:00 GMT Funding The Series D, led by Pershing Square, is among the largest rounds for a cortical-surface interface and brings the company's total funding to $430M. Evidence: independent reporting. https://bcibrief.com/article/paradromics-first-participant-speech/ https://bcibrief.com/article/paradromics-first-participant-speech/ Mon, 14 Sep 2026 12:00:00 GMT Clinical Three months after its first long-term implant, the company says a woman with motor neuron disease is choosing her own words through the Connexus BCI. No performance figures have been released. Evidence: company reported. https://bcibrief.com/article/ucsf-speech-and-gesture/ https://bcibrief.com/article/ucsf-speech-and-gesture/ Mon, 14 Sep 2026 12:00:00 GMT Research A UCSF team decoded attempted speech and upper-body gestures at the same time from a single surface array, moving communication BCIs closer to how people actually talk. Evidence: peer reviewed. https://bcibrief.com/article/libribrain100-cross-subject/ https://bcibrief.com/article/libribrain100-cross-subject/ Thu, 03 Sep 2026 12:00:00 GMT Dataset The largest open MEG speech dataset now adds 32 subjects, shifting the benchmark from how well a decoder learns one brain to how quickly it adapts to a new one. Evidence: preprint. https://bcibrief.com/article/ability-optical-link-study/ https://bcibrief.com/article/ability-optical-link-study/ Thu, 20 Aug 2026 12:00:00 GMT Clinical ABILITY Neurotech, a Geneva spin-out, is testing a battery-free ECoG implant with an infrared data link during surgery in Germany, and plans a one-year home study in people with ALS in Utrecht. Evidence: independent reporting. https://bcibrief.com/article/prima-european-launch/ https://bcibrief.com/article/prima-european-launch/ Wed, 22 Jul 2026 12:00:00 GMT Regulatory Science Corporation's PRIMA has been CE-marked for geographic atrophy and launched commercially in Europe, on the back of a multicentre trial published in NEJM. Evidence: company reported. https://bcibrief.com/article/china-pipeline-counted/ https://bcibrief.com/article/china-pipeline-counted/ Wed, 08 Jul 2026 12:00:00 GMT Clinical A preprint from Chinese clinicians tallies 134 registered trials, 26 investigator-initiated trials and five approved products, months after the country registered the first implanted BCI anywhere. Evidence: preprint.